Columbia Partners Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,365
| Closed | -$1.64M | – | 239 |
|
|
2017
Q4 | $1.64M | Sell |
4,365
-3,756
| -46% | -$1.41M | 0.22% | 130 |
|
|
2017
Q3 | $3.63M | Buy |
+8,121
| New | +$3.63M | 0.48% | 64 |
|
|
2017
Q2 | – | Sell |
-4,599
| Closed | -$1.78M | – | 265 |
|
|
2017
Q1 | $1.78M | Sell |
4,599
-660
| -13% | -$256K | 0.23% | 125 |
|
|
2016
Q4 | $1.93M | Sell |
5,259
-5,773
| -52% | -$2.12M | 0.17% | 177 |
|
|
2016
Q3 | $4.44M | Buy |
+11,032
| New | +$4.44M | 0.35% | 106 |
|
|
2016
Q2 | – | Sell |
-17,324
| Closed | -$6.24M | – | 361 |
|
|
2016
Q1 | $6.24M | Sell |
17,324
-6,157
| -26% | -$2.22M | 0.45% | 77 |
|
|
2015
Q4 | $12.7M | Buy |
23,481
+106
| +0.5% | +$57.5K | 0.88% | 22 |
|
|
2015
Q3 | $10.9M | Sell |
23,375
-487
| -2% | -$227K | 0.76% | 31 |
|
|
2015
Q2 | $12.2M | Sell |
23,862
-4,627
| -16% | -$2.36M | 0.75% | 30 |
|
|
2015
Q1 | $12.9M | Sell |
28,489
-1,058
| -4% | -$478K | 0.68% | 41 |
|
|
2014
Q4 | $12.1M | Sell |
29,547
-622
| -2% | -$255K | 0.63% | 50 |
|
|
2014
Q3 | $10.9M | Sell |
30,169
-492
| -2% | -$177K | 0.55% | 58 |
|
|
2014
Q2 | $8.66M | Sell |
30,661
-373
| -1% | -$105K | 0.4% | 90 |
|
|
2014
Q1 | $9.32M | Sell |
31,034
-81
| -0.3% | -$24.3K | 0.41% | 85 |
|
|
2013
Q4 | $8.56M | Sell |
31,115
-295
| -0.9% | -$81.2K | 0.37% | 101 |
|
|
2013
Q3 | $9.83M | Sell |
31,410
-617
| -2% | -$193K | 0.44% | 72 |
|
|
2013
Q2 | $7.2M | Buy |
+32,027
| New | +$7.2M | 0.34% | 108 |
|